January 1, 2025, marked a historic day for Florida civil litigation as the much-anticipated sweeping changes to the Florida Rules of Civil Procedure went into effect. These changes will fundamentally […]
https://fidjlaw.com/wp-content/uploads/2025/07/images-1.jpeg210240admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2025-01-21 12:44:092026-03-12 13:03:24Florida Civil Litigation Update: Major changes to the rules of civil procedure have gone into effect. Practitioners must be aware of the consequences for noncompliance.
I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her Endpoints News story about the case. Lilly’s lawsuit, filed […]
https://fidjlaw.com/wp-content/uploads/2025/07/iStock-1195014417-scaled-1.jpg17072560admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2025-01-14 12:44:092026-03-12 13:07:41Lilly v. FDA: Two Stories Collide to Make this GLP-1 Case a Tale of Our Time
On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of the five warning letters were to companies (specifically, Xcel […]
https://fidjlaw.com/wp-content/uploads/2025/07/iStock-1195014417-scaled-1.jpg17072560admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2024-12-20 12:44:092026-03-12 13:09:22FDA Issues Five Warning Letters to Makers of Knockoff GLP-1 Drugs
Author’s Note: This is an updated version of the post to our blog dated October 30, 2024. Later that day, FDA announced the resolution of Novo Nordisk’s semaglutide shortage, which […]
https://fidjlaw.com/wp-content/uploads/2025/07/iStock-1195014417-scaled-1.jpg17072560admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2024-11-04 12:44:092026-03-12 13:12:01COMPOUNDED GLP-1 DRUGS: IS THE PARTY OVER? THESE ARE THE LEGAL AND REGULATORY ISSUES FOR GAME CHANGING WEIGHT LOSS PRODUCTS AND THE COMPANIES SELLING THEM
Florida’s Second district court of appeal recently issued another opinion in the long line of decisions to determine the gatekeeping question of arbitration under the Revised Florida Arbitration Code, §§ […]
https://fidjlaw.com/wp-content/uploads/2025/07/image.png6411140admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2024-10-16 12:44:092026-03-12 13:15:40DOES THE FAILURE TO COMPLY WITH A PRE-SUIT MEDIATION CLAUSE RESULT IN THE WAIVER OF THE RIGHT TO ARBITRATION? ONLY THE ARBITRATOR KNOWS!
In close succession, the Supreme Court of the United States recently decided two short but meaningful cases that arbitration litigants must keep in mind: Coinbase, Inc. v. Suski, 144 S.Ct. […]
https://fidjlaw.com/wp-content/uploads/2025/07/iStock-1269677040.jpg53047952admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2024-07-01 12:44:092026-03-12 13:27:19“FOURTH-ORDER” ARBITRATION DISPUTES AND MANDATORY STAYS DURING ARBITRATION—A BUSY MONTH IN SUPREME COURT FOR ARBITRATION CASE LAW
The Corporate Transparency Act became law in the United States on January 1, 2021 and required compliance beginning on January 1, 2024. For more information about the background of the […]
Miguel J. Chamorro Specificity seldom hurts in litigation. It is indispensable if you want to prevent an arbitrator from arbitrating something you think a court should adjudicate instead. But although […]
https://fidjlaw.com/wp-content/uploads/2025/07/iStock-1497811812-scaled-1.jpg17072560admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2024-01-24 12:44:092026-03-13 10:55:07Arbitration in Action: When Challenging an Arbitration Agreement’s Delegation Clause, Do So Specifically—and Challenge the Right Thing
Florida litigators are well aware of the power of a properly used proposal for settlement and the potentially devastating consequences of rejecting such a proposal. Such proposals are powerful tools […]
https://fidjlaw.com/wp-content/uploads/2025/07/court-e1654090281527.webp7501120admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2024-01-23 12:44:092026-03-13 10:57:19Florida Litigation Update: Third DCA Clarifies When Joint Proposals for Settlement Are Ambiguous and Addresses the Interplay Between Joint Proposals and Indemnification Agreements.
A California man has been convicted of smuggling and misbranding tianeptine after selling the unapproved drug as a “mood enhancer.” By Manisha Krishnan September 13, 2023 A California man has […]
https://fidjlaw.com/wp-content/uploads/2025/07/Vice-Logo.jpg160390admin_fidjhttps://fidjlaw.com/wp-content/uploads/2007/02/FIDJ-Logo-Hero.svgadmin_fidj2023-10-31 12:44:092026-03-13 10:58:32Feds Get Rare ‘Gas Station Heroin’ Conviction
Florida Civil Litigation Update: Major changes to the rules of civil procedure have gone into effect. Practitioners must be aware of the consequences for noncompliance.
January 1, 2025, marked a historic day for Florida civil litigation as the much-anticipated sweeping changes to the Florida Rules of Civil Procedure went into effect. These changes will fundamentally […]
Lilly v. FDA: Two Stories Collide to Make this GLP-1 Case a Tale of Our Time
I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her Endpoints News story about the case. Lilly’s lawsuit, filed […]
FDA Issues Five Warning Letters to Makers of Knockoff GLP-1 Drugs
On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of the five warning letters were to companies (specifically, Xcel […]
COMPOUNDED GLP-1 DRUGS: IS THE PARTY OVER? THESE ARE THE LEGAL AND REGULATORY ISSUES FOR GAME CHANGING WEIGHT LOSS PRODUCTS AND THE COMPANIES SELLING THEM
Author’s Note: This is an updated version of the post to our blog dated October 30, 2024. Later that day, FDA announced the resolution of Novo Nordisk’s semaglutide shortage, which […]
DOES THE FAILURE TO COMPLY WITH A PRE-SUIT MEDIATION CLAUSE RESULT IN THE WAIVER OF THE RIGHT TO ARBITRATION? ONLY THE ARBITRATOR KNOWS!
Florida’s Second district court of appeal recently issued another opinion in the long line of decisions to determine the gatekeeping question of arbitration under the Revised Florida Arbitration Code, §§ […]
“FOURTH-ORDER” ARBITRATION DISPUTES AND MANDATORY STAYS DURING ARBITRATION—A BUSY MONTH IN SUPREME COURT FOR ARBITRATION CASE LAW
In close succession, the Supreme Court of the United States recently decided two short but meaningful cases that arbitration litigants must keep in mind: Coinbase, Inc. v. Suski, 144 S.Ct. […]
Corporate Transparency Act: Executive Summary
The Corporate Transparency Act became law in the United States on January 1, 2021 and required compliance beginning on January 1, 2024. For more information about the background of the […]
Arbitration in Action: When Challenging an Arbitration Agreement’s Delegation Clause, Do So Specifically—and Challenge the Right Thing
Miguel J. Chamorro Specificity seldom hurts in litigation. It is indispensable if you want to prevent an arbitrator from arbitrating something you think a court should adjudicate instead. But although […]
Florida Litigation Update: Third DCA Clarifies When Joint Proposals for Settlement Are Ambiguous and Addresses the Interplay Between Joint Proposals and Indemnification Agreements.
Florida litigators are well aware of the power of a properly used proposal for settlement and the potentially devastating consequences of rejecting such a proposal. Such proposals are powerful tools […]
Feds Get Rare ‘Gas Station Heroin’ Conviction
A California man has been convicted of smuggling and misbranding tianeptine after selling the unapproved drug as a “mood enhancer.” By Manisha Krishnan September 13, 2023 A California man has […]